Company Overview

Update
Founded:
1992
Headquarters:
Deutsch
IPO:
Went Public on Aug 27, 2013
Stock:
MPSYY
Categories:
Biotechnology
Description:
MorphoSys is a biotechnology company focused on the research and development of fully human antibodies.

Detailed Description

Update

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next generation of antibodies, which can be used to treat diseases and for research and diagnostics purposes. Numerous partnerships have already been entered into with well-known companies from the pharmaceutical and biotechnology sectors, such as Boehringer Ingelheim, Daiichi Sankyo, Merck & Co, Novartis, Pfizer, and Roche.

Current Team (10)

Update

Past Team (1)

Update

Funding Rounds (1) - $126M

Update

Acquisitions (1)

Update

Offices/Locations (1)

Update
  • Office

    Lena-Christ-Strasse 48

    82152 Martinsried/Planegg

    Deutsch,

    DEU

Images (1)

Update
  • Cd94e9837dbdb173c3b4d4e521ed9283